The molecular lab.
Anywhere.
Laboratory-grade answers, right where decisions are made.
Every setting
Whoever needs to know. Wherever they are.
Vivoxa brings the molecular laboratory to the point of need. A single run resolves multiple bacterial and viral pathogens, without a bench, a cold chain, or a technician.
Human infectious disease
Clinics and pharmacies, bringing laboratory-grade answers to the point of care.
Precision medicine & AMR
Identifying the exact pathogen and resistance profile, so treatment is targeted from the first dose.
Equine
Racing yards, stud farms and veterinary practices, testing at the stable door.
Companion animals
Vets testing cats and dogs for UTIs, ear and skin infections in the same visit.
Livestock
Dairy and farm health, from mastitis screening to herd-wide outbreaks.
Wildlife & zoonotic surveillance
Field sampling of bats, rodents and wild birds. Spillover pathogens are caught before they reach livestock or people.
Swipe or drag for more →
Inside the cartridge
Ten targets. One sample.
Read as light.
One swab, one run, multiple answers.
Collect
Place the swab into the buffer, then into the reader device. No tubes, no pipettes, no sample preparation.
Run
Close it and press start. Everything happens inside the kit, with nothing else to add and nothing else to set up.
Read
Scan the result online for interpretation and next-step guidance.
About
Founded by Oxford scientists.
Vivoxa was founded by scientists from the University of Oxford. Our team has the molecular biology expertise to develop the assays, the engineering to build the device, the strategy to take it to market, and prior experience in diagnostics companies.
Alara Urunga
Co-founder & CEO
MBiochem Biochemistry
Dr Johnny Zhou
Co-founder & COO
DPhil Biomedical Engineering
Vicente Trelles Fernandez
Engineer / Advisor
DPhil Engineering Science
Ellen Marsh
Engineer
DPhil Engineering Biology
Caitlin Chesnais-Dixon
Outreach Officer
MSc Health Innovation
Contact
Get in touch.
Vivoxa is pre-launch and we reply to everyone. Tell us who you are and what you'd use, and we'll be in touch as things move forward.